Industry-Sponsored Satellite Symposia

Open to all ACG 2018 attendees, industry-sponsored satellite symposia provide additional educational opportunities for attendees. These programs are independent of the ACG 2018 Annual Scientific Meeting & Postgraduate Course and ACG is not the continuing medical education provider for these programs.


The Microbiome in GI Conditions: Hope or Hype

Saturday, October 6, 2018 | 5:30 pm – 7:30 pm
Philadelphia Marriott Downtown • Salon GLK
Brennan M. Spiegel, MD, MSHS, FACG, William D. Chey, MD, FACG, Mark Pimentel, MD, FACG, Millie D. Long, MD, MPH, FACG
Drs. Brennan Spiegel, William Chey, and Mark Pimentel travel inside the microbiome-gut-brain axis in mixed reality in the "The Microbiome in GI Conditions: Hope or Hype?" live symposium. This educational offering will feature immersive technology and offer the latest evidence for the evolving role of the microbiome in gastrointestinal conditions that will be sure to educate as well as entertain.
Supported by an independent educational grant from Salix Pharmaceuticals.


Beyond TNF-Inhibitors: Optimizing Care for Patients With IBD

Saturday, October 6, 2018 | 5:30 pm – 7:30 pm
Philadelphia Marriott Downtown • Salon HIJ
Stephen B. Hanauer, MD, FACG (Chair), Miguel D. Regueiro, MD, FACG, and William J. Sandborn, MD, FACG
For more information and to register, visit www.GiHealthFoundation.org, email info@GiHealthFoundation.org, or call 1-877-782-4532.
Supported by educational grants from Janssen Biotech, Inc. and Pfizer, Inc.


Challenging Cases in PBC: Who's in Your Waiting Room?

Saturday, October 6, 2018 | 7:30 pm – 9:30 pm
Philadelphia Marriott Downtown • Franklin Hall 11-13
David E. Bernstein, MD, FACG, Steven L. Flamm, MD, FACG, Marlyn Mayo, MD
Utilizing a novel symposium approach, participants and faculty will be introduced to three different patient cases of primary biliary cholangitis (PBC) in a simulated waiting room. One-by-one, each patient will be called into the exam room to share their experience living with PBC, with the expert faculty and audience together exploring the best therapeutic approaches.
http://www.medscape.org/sympo/pbccasechallenges-registration
Supported by an independent educational grant from Intercept Pharmaceuticals.


CRC Screening: Deciphering New Guidelines to Enhance Your Practice

Saturday, October 6, 2018 | 7:30 pm – 9:30 pm
Philadelphia Marriott Downtown • Liberty Ballroom
Douglas J. Robertson, MD, MPH, Brooks D. Cash, MD, FACG, Deborah A. Fisher, MD, MHS, FACG
Controversy or conundrum? New guidelines on early colorectal cancer (CRC) screening are stirring debate, with different viewpoints on when to initiate testing and what methods to use. Through interactive presentations and case studies, attendees can cut through the confusion to better understand how to translate guidelines to direct individualized clinical decision making.
This program is supported by an educational grant from Exact Sciences.


Optimizing Colonoscopy Outcomes Through Quality Bowel Prep

Sunday, October 7, 2018 | 5:30 am – 7:30 am
Philadelphia Marriott Downtown • Salon GLK
Douglas K. Rex, MD, MACG, David A Johnson MD, MACG, Stacy B. Menees, MD
This live symposium will deliver key information and the latest data to equip clinicians in selection of optimal bowel preparation regimens for colonoscopy and will underscore the importance of recommendations for colorectal cancer screening, factors that influence quality of colonoscopy, and how to apply clinical data in to practice to guide decision-making and colonoscopy success.
Supported by an educational grant from Braintree Laboratories, Inc.


A Clinical Review of a New Prescription Treatment for Moderate to Severe Ulcerative Colitis from Pfizer

Sunday, October 7, 2018 | 7:30 pm – 9:30 pm
Philadelphia Marriott Downtown • Salon CDE
Stephen B. Hanauer, MD, FACG, Michael V. Chiorean, MD
Drs Stephen Hanauer and Michael Chiorean will discuss the clinical data and important practical considerations for a nonbiologic, advanced therapy for adult patients with moderately to severely active UC.
This program is sponsored by Pfizer.


Proactive Management in an Evolving GI Landscape: A Case-based Approach
For HCV: The Role of the HCV Specialist in the Pangenotypic Era
For IBD: Re-defining Disease and Stratifying Risk to Get Ahead of IBD

Sunday, October 7, 2018 | 7:30 pm – 9:30 pm
Philadelphia Marriott Downtown • Salon HIJ
Robert S. Brown, MD, MPH, FACG, Corey A. Siegel, MD, MS
This symposium will focus on chronic hepatitis C virus (HCV) infection and inflammatory bowel disease (IBD) using a case-based approach. The symposium will provide a brief overview of HCV management and discuss clinical considerations for specific patient groups, as well as the importance of risk stratification in IBD, and the value of defining disease severity when determining control strategies.
This program is sponsored by AbbVie.


Medical Mystery: A Case of Unexplained, Severe, Diffuse Abdominal Pain

Monday, October 8, 2018 | 7:00 pm – 9:00 pm
Philadelphia Marriott Downtown • Salon ABF
Sean R. Rudnick, MD
Perhaps you have certain patients who return with recurrent and severe abdominal pain without a working diagnosis. Navigate through a medical mystery, starting from a common complaint of severe, diffuse, abdominal pain to a complete diagnostic work-up on a disease that can easily be missed. To register, please go to www.eventenrollment.com.
This program is sponsored by Alnylam Pharmaceuticals.


Time for Action: The Urgent Need for Immunization in Patients With IBD

Monday, October 8, 2018 | 7:00 pm – 9:00 pm
Philadelphia Marriott Downtown • Salon HIJ
Millie D. Long, MD, MPH, FACG (Chair), Francis A. Farraye, MD, MSc, FACG, Gil Y. Melmed, MD, FACG
The goal of the proposed CME/CE activities is to provide clinicians with expert guidance on ACG recommendations and guidelines pertaining to the need for vaccination in patients with IBD and to provide suggestions on how to implement these strategies for optimal clinical outcomes. Clinicians should also be aware of the latest developments in vaccines appropriate for patients with IBD. This will result in an increase in the number of patients with IBD who receive preventive vaccinations. www.naccme.com/ActionIBD
Supported by an educational grant from Pfizer.


Paving a Path to Relief of Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Live Patient Simulations Demonstrating Innovations in Diagnosis and Treatment

Tuesday, October 9, 2018 | 5:30 am – 7:30 am
Philadelphia Marriott Downtown • Salon GLK
Lin Chang, MD, FACG, William D. Chey, MD, FACG
Efficient and effective diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) demand stepping away from a “cookie cutter” approach, given the heterogeneity of cases and the wide array of evaluative tests and symptom-relief strategies that are now (currently) available. Using live physician-patient simulations, this unique interactive symposium will allow you to choose among the myriad of potential IBS and CIC diagnostic and treatment pathways (strategies v pathways) for a variety of clinical scenarios—and witness how those clinical choices affect patient care and outcomes.
www.paradigmmc.com/763
This activity is supported by an educational grant from Allergan, Inc and Ironwood Pharmaceuticals, Inc.


Expert Perspectives on Chronic Constipation: Patient-Centered Approach to Care

Tuesday, October 9, 2018 | 7:00 pm – 9:00 pm
Philadelphia Marriott Downtown • Salon HIJ
William D. Chey, MD, FACG, Kyle D. Staller, MD, MPH, Brooks Cash, MD, FACG
This dinner program will contain three areas of focus. The first presentation will discuss physician and patient perspectives on chronic constipation by Dr. William Chey. Secondly, Dr. Kyle Staller will provide an overview of CIC pathophysiology. Finally, an update on clinical care of chronic constipation will be presented by Dr. Brooks Cash. After the presentations and panel discussion concludes, there will be a question and answer period.
This program is sponsored by Shire Medical.